secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2026-06-09T21:20:47+00:00
Accession:  0001193125-26-264047
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome adopts Executive Severance Plan with CIC benefits for officers
---------------------------------------------------------------------

- Plan effective June 5, 2026, covers CEO (Tier 1), other Section 16 execs (Tier 2), and VPs+ (Tier 3).
- Outside CIC: CEO gets 18 months base salary plus 18 months COBRA; Tier 2 gets 12 months base plus COBRA.
- Inside CIC: CEO gets 24 months base plus target bonus, 24 months COBRA, and full equity vesting.
- Tier 2 inside CIC: 18 months base plus bonus, 18 months COBRA, full equity vesting; Tier 3: 9 months package.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000119312526264047/0001193125-26-264047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000119312526264047/axsm-20260605.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-264047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer